OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development
/PRNewswire/ -- OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera...
Source: prnewswire.com